玻璃体切割手术治疗增生型糖尿病视网膜病变的疗效观察

发布时间：2018-02-07 10:50

本文关键词： 玻璃体切割手术型糖尿病增生型糖尿病视网膜病变　出处：《眼科新进展》2017年03期 　论文类型：期刊论文

【摘要】：目的评估玻璃体切割手术治疗1型糖尿病(diabetes mellitus,DM)所致增生型糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)的临床疗效及并发症特点。方法回顾性分析2010年1月至2016年1月于我院确诊为PDR并行玻璃体切割手术治疗的18例(28眼)小于30岁的1型DM患者的临床资料,观察术后视力改善程度及术中、术后并发症。结果术后随访6~72(平均43.0)个月,23眼(82.1%)术后视力维持或改善,5眼(17.9%)视力下降,其中无光感2眼(7.1%);1次手术复位视网膜脱离12眼(92.3%);术中并发症为医源性视网膜裂孔3眼;术后并发症:前房炎症反应9眼,前房积血5眼,复发性玻璃体积血2眼,复发性视网膜脱离3眼,虹膜红变5眼,新生血管性青光眼4眼。结论玻璃体切割手术可以很好地恢复年轻1型DM所致PDR患者的视网膜解剖结构及功能,术后新生血管相关性并发症重,需行充足全视网膜光凝及术前抗VEGF注药治疗。
[Abstract]:Objective to evaluate the clinical efficacy and complications of vitrectomy in the treatment of proliferative diabetic retinopathy caused by type 1 diabetes mellitus (DM). Methods from January 2010 to January 2016 in our hospital, we retrospectively analyzed the clinical efficacy and complications of vitrectomy in the treatment of proliferative diabetic retinopathy. Clinical data of 18 patients (28 eyes) with PDR and vitrectomy) who were less than 30 years old in type 1 DM patients. Results the postoperative visual acuity was maintained or improved in 5 eyes (17.9%). The postoperative complications were iatrogenic retinal tears in 3 eyes, anterior chamber inflammation in 9 eyes, hyphema in 5 eyes, recurrent vitreous hemorrhage in 2 eyes, and recurrent vitreous hemorrhage in 2 eyes. There were 3 eyes of recurrent retinal detachment, 5 eyes of iris redness and 4 eyes of neovascular glaucoma. Conclusion vitrectomy can restore the retinal anatomy and function of young patients with PDR caused by type 1 DM. The complications of neovascularization were serious, which needed to be treated with adequate total retinal photocoagulation and preoperative anti-VEGF injection.
【作者单位】：天津医科大学眼科医院天津医科大学眼视光学院;
【基金】：新疆维吾尔自治区自然科学基金资助(编号:20131801-11)~~
【分类号】：R779.6;R587.2

【相似文献】